𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Usefulness of proviral load measurement for monitoring of disease activity in individual patients with human T-lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis

✍ Scribed by Norihiro Takenouchi; Yoshihisa Yamano; Koichiro Usuku; Mitsuhiro Osame; Shuji Izumo

Book ID
111739178
Publisher
Springer US
Year
2003
Tongue
English
Weight
286 KB
Volume
9
Category
Article
ISSN
1355-0284

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Molecular and clinical effects of betame
Molecular and clinical effects of betamethasone in human t-cell lymphotropic virus type-i-associated myelopathy/tropical spastic paraparesis patients
✍ Carolina Alberti; Luis Cartier; María A. Valenzuela; Javier Puente; Yuetsu Tanak 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 384 KB

## Abstract There is no effective therapy for human T‐cell lymphotropic virus type I (HTLV‐I)‐associated myelopathy/tropical spastic paraparesis (HAM/TSP). Glucocorticoids are effective to reduce the motor disability in these patients, but its role as anti‐spastic drugs is unknown. Here it is repor

Human T cell lymphotropic virus type 1 (
Human T cell lymphotropic virus type 1 (HTLV-1) proviral load of HTLV-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients according to new diagnostic criteria of HAM/TSP
✍ Maria Fernanda Rios Grassi; Viviana Nilla Olavarria; Ramon de Almeida Kruschewsk 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB

## Abstract A high human T‐cell lymphotropic virus type 1 (HTLV‐1) proviral load is described in HTLV‐1‐associated diseases, especially HAM/TSP. However, the cut‐off value to define high levels of HTLV‐1 proviral load is not well established. 281 HTLV‐1‐infected patients from the HTLV reference cen